MDxHealth, Ghent University Form Epigenomics Center | GenomeWeb

NEW YORK (GenomeWeb News) – MDxHealth and Ghent University announced today that they have formed a new epigenetics research center to accelerate innovations in personalized medicine.

The partners have established NXTGNT, a Center in Pharmaco (Epi)genomics, at Ghent University within its laboratory of pharmaceutical biotechnology. The Center, which will be fully operational as of Dec. 1, will bring together disease-centered basic researchers, clinical validation teams, and bioinformaticians to apply epigenomics technology to personalized medicine.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.